Skip to main content
. 2021 Sep 2;338:537–547. doi: 10.1016/j.jconrel.2021.08.061

Fig. 7.

Fig. 7

Humoral and cellular immune responses of PVES/mRNA vaccine. (A) Schematic diagram of immunization, sample collection. (B) The SARS-CoV-2 Spike/RBD specific IgG antibody titer was determined by ELISA. The dashed line indicated the detection limit of the assay. mRNA indicated 30 μg mRNA control group, 5 μg, 10 μg and 30 μg represent PVES/mRNA complexes. Data were shown as mean ± SM. (C, D) Cellular immune responses were evaluated by intracellular cytokine staining assays, the proportions of IL-4-secreting CD4+ and IFN-γ-secreting CD8+ T cells were quantified. Data were shown as mean ± SM. Significance was calculated using one-way ANOVA (****, P < 0.0001).